iSpecimen Inc (ISPC)
0.2346
-0.01
(-5.56%)
USD |
NASDAQ |
May 21, 11:31
iSpecimen Gross Profit Margin (Quarterly): 56.33% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 56.33% |
December 31, 2023 | 44.58% |
September 30, 2023 | 49.87% |
June 30, 2023 | 47.47% |
March 31, 2023 | 61.12% |
December 31, 2022 | 52.40% |
September 30, 2022 | 54.26% |
June 30, 2022 | 57.25% |
March 31, 2022 | 53.71% |
December 31, 2021 | 52.05% |
Date | Value |
---|---|
September 30, 2021 | 66.39% |
June 30, 2021 | 48.72% |
March 31, 2021 | 45.22% |
December 31, 2020 | 42.84% |
September 30, 2020 | 59.83% |
June 30, 2020 | 68.50% |
March 31, 2020 | 61.78% |
December 31, 2019 | 51.87% |
September 30, 2019 | 29.74% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
29.74%
Minimum
Sep 2019
68.50%
Maximum
Jun 2020
52.84%
Average
52.40%
Median
Dec 2022
Gross Profit Margin (Quarterly) Benchmarks
RadNet Inc | 10.22% |
DermTech Inc | 18.54% |
23andMe Holding Co | 44.55% |
Sera Prognostics Inc | -- |
Progyny Inc | 22.44% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -93.22% |
Return on Assets | -68.76% |
Return on Invested Capital | -93.22% |
Profit Margin (Quarterly) | -126.7% |
Operating Margin (Quarterly) | -131.0% |
Return on Net Operating Assets | -115.9% |